73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&

Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&
AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

byJohns Hopkins University School of MedicineCredit: Carolyn Hruban, Ph.D.A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers coul

AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

byJohns Hopkins University School of MedicineCredit: Carolyn Hruban, Ph.D.A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers coul
Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r

Frontline Immunotherapy, Delayed Nephrectomy May Allow for Improved Disease Control in mRCC

July 14, 2023Caroline SeymourNeoadjuvant immunotherapy–based combinations led to reductions in tumor size and pathologic necrosis at the time of cytoreductive nephrectomy in patients with metastatic r
Australia on track to be the first country to eliminate cervical cancer, but inequities persist

Australia on track to be the first country to eliminate cervical cancer, but inequities persist

by Dr Tessa Saunders, Dr Claire Nightingale, Associate Professor Megan Smith and Claire Bavor,University of MelbourneSelf-screening for HPV is one way to remove barriers to screening. Credit: Au

Australia on track to be the first country to eliminate cervical cancer, but inequities persist

by Dr Tessa Saunders, Dr Claire Nightingale, Associate Professor Megan Smith and Claire Bavor,University of MelbourneSelf-screening for HPV is one way to remove barriers to screening. Credit: Au
Team identify molecule that suppresses melanoma tumors

Team identify molecule that suppresses melanoma tumors

byUniversity of BathMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A promising route to develop new treatments f

Team identify molecule that suppresses melanoma tumors

byUniversity of BathMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A promising route to develop new treatments f
Advanced imaging may help in clinical treatment of prostate cancer

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare

Advanced imaging may help in clinical treatment of prostate cancer

byEuropean Association of UrologyCredit: Pixabay/CC0 Public DomainAn advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a cleare
Radiotherapy for ductal in situ carcinoma ups mortality risk in invasive second breast cancer

Radiotherapy for ductal in situ carcinoma ups mortality risk in invasive second breast cancer

(HealthDay)—For women with primary ductal carcinoma in situ (DCIS), use of radiotherapy (RT) is associated with increased rates of breast cancer-specific mortality for those women who subsequently dev

Radiotherapy for ductal in situ carcinoma ups mortality risk in invasive second breast cancer

(HealthDay)—For women with primary ductal carcinoma in situ (DCIS), use of radiotherapy (RT) is associated with increased rates of breast cancer-specific mortality for those women who subsequently dev
PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci

PD-1/VEGFR-2 Inhibitor Combo Shows Durable Responses in Nasopharyngeal Carcinoma

February 10, 2023Ashling WahnerThe combination of camrelizumab and apatinib led to long-term antitumor activity with manageable toxicities in patients with recurrent or metastatic nasopharyngeal carci
Belzutifan outperforms everolimus in advanced kidney cancer treatment

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,
Tracking genes to fight breast cancer

Tracking genes to fight breast cancer

byLeiden UniversityMicroscope image of moving breast cancer cells leaving a track. Koedoot: "We switched of certain proteins and then looked to see if the pathways changed." Credit: Es

Tracking genes to fight breast cancer

byLeiden UniversityMicroscope image of moving breast cancer cells leaving a track. Koedoot: "We switched of certain proteins and then looked to see if the pathways changed." Credit: Es
Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an